athenahealth, Inc. (NASDAQ:ATHN) CEO Jonathan Bush sold 4,000 shares of the stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $143.31, for a total value of $573,240.00. Following the sale, the chief executive officer now owns 319,807 shares in the company, valued at approximately $45,831,541.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Jonathan Bush also recently made the following trade(s):

  • On Monday, July 3rd, Jonathan Bush sold 4,000 shares of athenahealth stock. The shares were sold at an average price of $140.52, for a total value of $562,080.00.
  • On Thursday, May 18th, Jonathan Bush sold 4,000 shares of athenahealth stock. The shares were sold at an average price of $125.85, for a total value of $503,400.00.

athenahealth, Inc. (NASDAQ ATHN) traded down 2.56% during midday trading on Thursday, hitting $141.68. The stock had a trading volume of 608,854 shares. The company’s 50 day moving average price is $143.27 and its 200-day moving average price is $124.42. The stock has a market capitalization of $5.66 billion, a price-to-earnings ratio of 177.10 and a beta of 1.77. athenahealth, Inc. has a 52 week low of $90.11 and a 52 week high of $158.66.

athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, beating the consensus estimate of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The company had revenue of $301.10 million for the quarter, compared to analyst estimates of $298.68 million. During the same quarter in the prior year, the company earned $0.34 EPS. The firm’s revenue for the quarter was up 15.0% compared to the same quarter last year. Equities analysts anticipate that athenahealth, Inc. will post $1.91 earnings per share for the current fiscal year.

WARNING: “Jonathan Bush Sells 4,000 Shares of athenahealth, Inc. (ATHN) Stock” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/08/03/jonathan-bush-sells-4000-shares-of-athenahealth-inc-athn-stock.html.

Large investors have recently made changes to their positions in the stock. Wesbanco Bank Inc. acquired a new stake in shares of athenahealth during the first quarter valued at approximately $714,000. Russell Investments Group Ltd. raised its stake in shares of athenahealth by 380.8% in the first quarter. Russell Investments Group Ltd. now owns 5,409 shares of the health services provider’s stock valued at $609,000 after buying an additional 4,284 shares during the last quarter. Nikko Asset Management Americas Inc. raised its stake in shares of athenahealth by 113.5% in the first quarter. Nikko Asset Management Americas Inc. now owns 7,900 shares of the health services provider’s stock valued at $890,000 after buying an additional 4,200 shares during the last quarter. Barton Investment Management raised its stake in shares of athenahealth by 3.9% in the first quarter. Barton Investment Management now owns 225,346 shares of the health services provider’s stock valued at $25,394,000 after buying an additional 8,511 shares during the last quarter. Finally, Riverbridge Partners LLC raised its stake in shares of athenahealth by 2.0% in the first quarter. Riverbridge Partners LLC now owns 1,057,142 shares of the health services provider’s stock valued at $119,129,000 after buying an additional 20,971 shares during the last quarter.

Several equities analysts recently issued reports on the company. UBS AG set a $123.00 price target on athenahealth and gave the company a “buy” rating in a report on Monday, May 1st. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $142.00 price target on shares of athenahealth in a report on Wednesday, April 19th. Piper Jaffray Companies reiterated a “buy” rating and issued a $152.00 price target on shares of athenahealth in a report on Friday, July 14th. Morgan Stanley reiterated an “equal weight” rating and issued a $125.00 price target (up previously from $108.00) on shares of athenahealth in a report on Wednesday. Finally, SunTrust Banks, Inc. reiterated a “buy” rating and issued a $170.00 price target (up previously from $150.00) on shares of athenahealth in a report on Wednesday. Three equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and thirteen have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $148.64.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.